PNC Financial Services Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.6M | Buy |
135,201
+6,947
| +5% | +$1.31M | 0.01% | 389 |
|
|
2026
Q1 | $25.3M | Buy |
128,254
+5,515
| +4% | +$1.06M | 0.01% | 382 |
|
|
2025
Q4 | $22.6M | Sell |
122,739
-2,754
| -2% | -$483K | 0.01% | 401 |
|
|
2025
Q3 | $19.3M | Buy |
125,493
+4,952
| +4% | +$749K | 0.01% | 415 |
|
|
2025
Q2 | $16.8M | Sell |
120,541
-3,549
| -3% | -$497K | 0.01% | 429 |
|
|
2025
Q1 | $18.2M | Buy |
124,090
+14,277
| +13% | +$2.07M | 0.01% | 407 |
|
|
2024
Q4 | $14.4M | Sell |
109,813
-9,301
| -8% | -$1.3M | 0.01% | 450 |
|
|
2024
Q3 | $18.6M | Buy |
119,114
+2,290
| +2% | +$370K | 0.01% | 407 |
|
|
2024
Q2 | $18.2M | Buy |
116,824
+455
| +0.4% | +$68.5K | 0.01% | 406 |
|
|
2024
Q1 | $15.8M | Sell |
116,369
-802
| -0.7% | -$106K | 0.01% | 432 |
|
|
2023
Q4 | $15.8M | Buy |
117,171
+1,613
| +1% | +$210K | 0.01% | 417 |
|
|
2023
Q3 | $15.7M | Sell |
115,558
-13,594
| -11% | -$1.86M | 0.01% | 399 |
|
|
2023
Q2 | $18.5M | Buy |
129,152
+630
| +0.5% | +$92.7K | 0.02% | 390 |
|
|
2023
Q1 | $17.8M | Buy |
128,522
+240
| +0.2% | +$32.3K | 0.02% | 392 |
|
|
2022
Q4 | $17.4M | Sell |
128,282
-2,722
| -2% | -$341K | 0.02% | 389 |
|
|
2022
Q3 | $14.4M | Buy |
131,004
+10,423
| +9% | +$1.32M | 0.02% | 406 |
|
|
2022
Q2 | $15.9M | Sell |
120,581
-23,495
| -16% | -$3.08M | 0.02% | 405 |
|
|
2022
Q1 | $19.1M | Sell |
144,076
-18,856
| -12% | -$2.26M | 0.02% | 396 |
|
|
2021
Q4 | $19M | Sell |
162,932
-3,762
| -2% | -$443K | 0.02% | 419 |
|
|
2021
Q3 | $20M | Buy |
166,694
+14,597
| +10% | +$1.7M | 0.02% | 386 |
|
|
2021
Q2 | $18.2M | Buy |
152,097
+37,038
| +32% | +$4.06M | 0.02% | 406 |
|
|
2021
Q1 | $11.4M | Sell |
115,059
-23,235
| -17% | -$2.34M | 0.01% | 476 |
|
|
2020
Q4 | $13.8M | Sell |
138,294
-2,355
| -2% | -$249K | 0.01% | 432 |
|
|
2020
Q3 | $15.4M | Buy |
140,649
+12,457
| +10% | +$1.39M | 0.02% | 380 |
|
|
2020
Q2 | $13.6M | Sell |
128,192
-16,787
| -12% | -$1.73M | 0.02% | 393 |
|
|
2020
Q1 | $12.9M | Sell |
144,979
-11,343
| -7% | -$1.07M | 0.02% | 377 |
|
|
2019
Q4 | $15.6M | Sell |
156,322
-1,433
| -0.9% | -$135K | 0.02% | 394 |
|
|
2019
Q3 | $14.1M | Buy |
157,755
+292
| +0.2% | +$25.3K | 0.01% | 405 |
|
|
2019
Q2 | $13M | Sell |
157,463
-4,096
| -3% | -$321K | 0.01% | 459 |
|
|
2019
Q1 | $13.1M | Sell |
161,559
-23,686
| -13% | -$1.87M | 0.01% | 454 |
|
|
2018
Q4 | $14.1M | Sell |
185,245
-23,832
| -11% | -$1.86M | 0.02% | 420 |
|
|
2018
Q3 | $16.5M | Sell |
209,077
-19,781
| -9% | -$1.5M | 0.02% | 433 |
|
|
2018
Q2 | $16.1M | Sell |
228,858
-6,829
| -3% | -$491K | 0.02% | 427 |
|
|
2018
Q1 | $16.5M | Buy |
235,687
+4,913
| +2% | +$340K | 0.02% | 429 |
|
|
2017
Q4 | $16M | Buy |
230,774
+112,121
| +94% | +$7.56M | 0.02% | 435 |
|
|
2017
Q3 | $8.04M | Buy |
118,653
+7,967
| +7% | +$503K | 0.01% | 556 |
|
|
2017
Q2 | $7.55M | Buy |
110,686
+8,274
| +8% | +$540K | 0.01% | 568 |
|
|
2017
Q1 | $6.38M | Buy |
102,412
+27,915
| +37% | +$1.62M | 0.01% | 604 |
|
|
2016
Q4 | $4.07M | Buy |
74,497
+271
| +0.4% | +$15.4K | ﹤0.01% | 730 |
|
|
2016
Q3 | $4.88M | Buy |
74,226
+30,849
| +71% | +$2.02M | 0.01% | 667 |
|
|
2016
Q2 | $2.62M | Buy |
43,377
+1,412
| +3% | +$82K | ﹤0.01% | 837 |
|
|
2016
Q1 | $2.36M | Sell |
41,965
-6
| -0% | -$361 | ﹤0.01% | 870 |
|
|
2015
Q4 | $2.85M | Sell |
41,971
-76,611
| -65% | -$5.02M | ﹤0.01% | 778 |
|
|
2015
Q3 | $7.55M | Buy |
118,582
+32,902
| +38% | +$2.16M | 0.01% | 548 |
|
|
2015
Q2 | $5.46M | Buy |
85,680
+16,245
| +23% | +$1.11M | 0.01% | 663 |
|
|
2015
Q1 | $4.75M | Buy |
69,435
+7,391
| +12% | +$514K | 0.01% | 689 |
|
|
2014
Q4 | $4.37M | Buy |
62,044
+4,247
| +7% | +$304K | ﹤0.01% | 692 |
|
|
2014
Q3 | $4.13M | Buy |
57,797
+958
| +2% | +$70.1K | ﹤0.01% | 701 |
|
|
2014
Q2 | $4.22M | Sell |
56,839
-2,431
| -4% | -$176K | 0.01% | 670 |
|
|
2014
Q1 | $3.84M | Buy |
59,270
+2,810
| +5% | +$181K | 0.01% | 675 |
|
|
2013
Q4 | $3.35M | Sell |
56,460
-9,177
| -14% | -$499K | ﹤0.01% | 708 |
|
|
2013
Q3 | $3.41M | Buy |
65,637
+2,923
| +5% | +$147K | 0.01% | 687 |
|
|
2013
Q2 | $2.97M | Buy |
+62,714
| New | +$3.19M | ﹤0.01% | 698 |
|
Other funds holding AZN
EPGL
RG
SAM
CDDEC
MGP
PNC Financial Services Group's AZN Position: Q2 2026 in Review
PNC Financial Services Group increased its AstraZeneca (AZN) stake by 5.4% in Q2 2026, buying an estimated $1.31M and bringing the position to 135,201 shares worth $25.6M. The position accounts for 0.01% of the portfolio, ranked #389.
PNC Financial Services Group first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- PNC Financial Services Group held 135,201 shares of AstraZeneca worth $25.6M as of Q2 2026.
- PNC Financial Services Group bought 6,947 AstraZeneca shares in Q2 2026, an estimated $1.31M.
- AstraZeneca made up 0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #389 holding.
- PNC Financial Services Group first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.